Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study

Peer Review reports

Original Submission
24 Jan 2013	Submitted	Original manuscript
31 Jan 2013	Author responded	Author comments - Lenard Adler
Resubmission - Version 2
31 Jan 2013	Submitted	Manuscript version 2
Resubmission - Version 3
	Submitted	Manuscript version 3
7 Feb 2013	Author responded	Author comments - Lenard Adler
Resubmission - Version 4
7 Feb 2013	Submitted	Manuscript version 4
28 Feb 2013	Reviewed	Reviewer Report - Wolfgang Retz
19 Mar 2013	Reviewed	Reviewer Report - Ronna Fried
10 Apr 2013	Reviewed	Reviewer Report - Cesar Soutullo
20 Jun 2013	Author responded	Author comments - Lenard Adler
Resubmission - Version 5
20 Jun 2013	Submitted	Manuscript version 5
6 Jul 2013	Reviewed	Reviewer Report - Cesar Soutullo
13 Jul 2013	Reviewed	Reviewer Report - Wolfgang Retz
Resubmission - Version 6
	Submitted	Manuscript version 6
Publishing
6 Sep 2013	Editorially accepted
9 Oct 2013	Article published	10.1186/1471-244X-13-253

Back to article page